试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私政策
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Tim-3 Ligand 的热门建议
Galectin
-3
Ligand-
Receptor
PD-1 Structure
Tim-3
Antibody
Tim3
CD8
Cd3ζ
LAG-3
Protein
Immune
Cell
Tim1
Signal
Tim29 Tim
Complex
Immune Checkpoint
Inhibitor
Tim3
Lung
Ndi
Ligand
Immune
Modulations
CD28 PI3K
Grb2 Cart
Cell
Exhaustion
T-cell Differentiation Pathway
Immune Checkpoint
Blockade
LAG-3
Recombinatant Protein
Immune Checkpoint
Inhibitors
Interleukin-3
Signaling Pathway
Membrane
Immunoglobulin
Immune Checkpoint Inhibitor PD-1 CTLA-4
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
仅限颜色
黑白
类型
全部
照片
剪贴画
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
仅脸部
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
清除筛选条件
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
Galectin
-3
Ligand-
Receptor
PD-1 Structure
Tim-3
Antibody
Tim3
CD8
Cd3ζ
LAG-3
Protein
Immune
Cell
Tim1
Signal
Tim29 Tim
Complex
Immune Checkpoint
Inhibitor
Tim3
Lung
Ndi
Ligand
Immune
Modulations
CD28 PI3K
Grb2 Cart
Cell
Exhaustion
T-cell Differentiation Pathway
Immune Checkpoint
Blockade
LAG-3
Recombinatant Protein
Immune Checkpoint
Inhibitors
Interleukin-3
Signaling Pathway
Membrane
Immunoglobulin
Immune Checkpoint Inhibitor PD-1 CTLA-4
873×720
118.31.76.100
【7.8.4.1】TIM-3 - Sam' Note
600×600
glpbio.com
TIM-3-IN-1|Cas#
850×829
researchgate.net
TIM-3 signaling pathway. A When an anti-TIM-3 therapy in…
1072×1920
prosci-inc.com
TIM-3 Antibody - Cat. No. 8659 …
320×320
researchgate.net
Functional associations of Tim-3. (A) Gene ontology analysi…
900×481
bio-techne.com
TIM-3 Protein: An Emerging Target for Cancer Immunotherapy | Bio-Techne
2500×1409
jrnlclub.org
TIM-3 restrains anti-tumour immunity by regulating inflammasome ...
1500×1586
blog.crownbio.com
What's Next for Immune Checkpoin…
850×454
researchgate.net
Mechanism of action of Tim-3 and PD-1 antibodies. Inhibition of the ...
1778×1768
prosci-inc.com
TIM-3 Antibody - Cat. No. RF16107 | ProSci
571×1280
researchgate.net
Blockade of the Tim-3–Tim-3L …
850×252
researchgate.net
TIM-3 ligands and their role in cancer. | Download Scientific Diagram
320×320
researchgate.net
Blockade of the Tim-3–Tim-3L pathway alon…
320×320
researchgate.net
Blockade of the Tim-3–Tim-3L pathway alon…
640×640
researchgate.net
| Soluble-TIM3 pathway and soluble-TIM3 functional c…
320×320
ResearchGate
(PDF) Tim-3, Lag-3, and TIGIT
650×2503
fishersci.com
TIM3 Polyclonal Antibody, Invitr…
650×643
thermofisher.com
TIM3 Monoclonal Antibody (G003.1) (34073-100UL)
850×470
researchgate.net
The importance of TIM-3 and LAG-3 expression in the microenvironment ...
1024×768
Thermo Fisher Scientific
TIM3 Antibody (60355-1-IG)
739×526
researchgate.net
T cell immunoglobulin and mucin domain 3 (TIM-3), its ligands, …
640×640
researchgate.net
Ligands and functions of Tim-3 on differen…
487×545
researchgate.net
Expression of Tim-3 and its specific lig…
850×351
researchgate.net
| TIM-3, its ligands, and signal transduction events. Gal-9, PtdSer ...
626×626
researchgate.net
| TIM-3, its ligands, and signal transdu…
320×320
researchgate.net
Ligands and functions of Tim-3 …
872×426
semanticscholar.org
Figure 1 from The Role of TIM-3 and LAG-3 in the Microenvironment and ...
2690×2630
MDPI
IJMS | Free Full-Text | TIM-3 as a Target …
1200×628
pubs.acs.org
Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia ...
500×187
pubs.acs.org
Prediction of the Peptide–TIM3 Binding Site in Inhibiting TIM3–Galectin ...
685×368
x-mol.com
TIM3 comes of age as an inhibitory receptor.,Nature Reviews Immunology ...
375×375
x-mol.com
Spatial distribution and functional analysis de…
685×440
newsletter.x-mol.com
TIM-3 as a promising target for cancer immunotherapy in a wide range of ...
400×266
cusabio.com
What are immune checkpoint pathways?-CUSABIO
440×438
ncbi.nlm.nih.gov
Fig. 2, [Structure of TIM-3 molecule and...]. - Innovati…
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
反馈
反馈
